Prognostic and predictive value of radiomic signature in stage I lung adenocarcinomas following complete lobectomy

BACKGROUND: The overall survival (OS) of stage I operable lung cancer is relatively low, and not all patients can benefit from adjuvant chemotherapy. This study aimed to develop and validate a radiomic signature (RS) for prediction of OS and adjuvant chemotherapy candidates in stage I lung adenocarc...

Descripción completa

Detalles Bibliográficos
Autores principales: Nie, Wei, Tao, Guangyu, Lu, Zhenghai, Qian, Jie, Ge, Yaqiong, Wang, Shuyuan, Zhang, Xueyan, Zhong, Hua, Yu, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331779/
https://www.ncbi.nlm.nih.gov/pubmed/35902907
http://dx.doi.org/10.1186/s12967-022-03547-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331779/
https://www.ncbi.nlm.nih.gov/pubmed/35902907
http://dx.doi.org/10.1186/s12967-022-03547-9

Ejemplares similares